Homology Medicines, Inc. (FIXX) Financials

NASDAQ Currency in USD Disclaimer

$0.93

north_east NA Past Year
Day's range
$0.9
Day's range
$0.97

FIXX Income statement / Annual

Last year (2023), Homology Medicines, Inc.'s total revenue was $1.16 M, a decrease of 63.97% from the previous year. In 2023, Homology Medicines, Inc.'s net income was -$112.96 M. See Homology Medicines, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $1.16 M $3.21 M $33.97 M $2.70 M $1.67 M $3.68 M $0.00 $0.00
Cost of Revenue $578,000.00 $2.60 M $9.54 M $100.39 M $89.40 M $0.00 $0.00 $0.00
Gross Profit $578,000.00 $609,000.00 $24.43 M -$97.69 M -$87.73 M $3.68 M $0.00 $0.00
Gross Profit Ratio 0.5 0.19 0.72 -36.15 -52.66 1 0 0
Research and Development Expenses $62.00 M $98.35 M $93.09 M $100.39 M $89.40 M $47.95 M $21.38 M $5.69 M
General & Administrative Expenses $31.26 M $38.14 M $36.84 M $32.57 M $22.21 M $17.30 M $8.28 M $4.31 M
Selling & Marketing Expenses -$578,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $30.68 M $38.14 M $36.84 M $32.57 M $22.21 M $17.30 M $8.28 M $4.31 M
Other Expenses $9.33 M $0.00 $0.00 $0.00 $0.00 $0.00 -$876,000.00 $1.93 M
Operating Expenses $92.68 M $136.49 M $129.92 M $132.97 M $111.61 M $65.25 M $29.66 M $10.00 M
Cost And Expenses $93.26 M $136.49 M $129.92 M $132.97 M $111.61 M $65.25 M $29.66 M $10.00 M
Interest Income $5.58 M $3.23 M $185,000.00 $1.57 M $6.03 M $4.35 M $542,635.00 $24,201.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $578,000.00 -$129.96 M $8.35 M $7.97 M $6.32 M $1.29 M $684,214.00 $239,797.00
EBITDA -$91.52 M -$133.28 M -$87.60 M -$122.30 M -$103.63 M -$60.28 M -$28.97 M -$9.76 M
EBITDA Ratio -79.17 -82.06 -2.58 -45.26 -62.2 -16.36 0 0
Operating Income Ratio -79.67 -41.55 -2.82 -48.21 -65.99 -16.71 0 0
Total Other Income/Expenses Net $14.35 M $134.48 M $185,000.00 $1.57 M $6.03 M $4.35 M -$333,365.00 $1.95 M
Income Before Tax -$87.08 M $1.20 M -$95.76 M -$128.69 M -$103.92 M -$57.22 M -$29.99 M -$8.05 M
Income Before Tax Ratio -75.33 0.37 -2.82 -47.63 -62.37 -15.53 0 0
Income Tax Expense $25.88 M $715,000.00 -$185,000.00 -$1.57 M -$6.03 M $4.35 M -$542,635.00 -$24,201.00
Net Income -$112.96 M $483,000.00 -$95.58 M -$127.13 M -$97.89 M -$57.22 M -$29.99 M -$8.05 M
Net Income Ratio -97.72 0.15 -2.81 -47.05 -58.76 -15.53 0 0
EPS -351.57 1.51 -311.2 -498.41 -418.35 -360.7 -159.96 -77.86
EPS Diluted -351.57 1.51 -311.2 -498.41 -418.35 -360.7 -159.96 -77.86
Weighted Average Shares Out $321,304.00 $318,887.00 $307,129.00 $255,059.00 $233,987.00 $158,621.00 $187,487.00 $103,346.00
Weighted Average Shares Out Diluted $321,304.00 $318,887.00 $307,129.00 $255,059.00 $233,987.00 $158,621.00 $187,487.00 $103,346.00
Link